http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0025287-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a8659631bf38b3a590c0d3edc265492c |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D503-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D503-00 |
| filingDate | 1980-08-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4a445821108e5764a2ebd50d63524388 |
| publicationDate | 1981-03-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-0025287-A1 |
| titleOfInvention | Clavulanic acid derivatives, their preparation, pharmaceutical compositions containing them and their preparation |
| abstract | This invention provides compounds of the formula (I);n and pharmaceutically acceptable salts and in-vivo hydrolysable esters thereof wherein R 1 is a hydrogen atom or a C 1-6 alkyl group, R 2 is a hydrogen atom or a C 1 6 alkylgroup, R 3 is a hydrogen atom or a C 1 6 alkyl group, or R 2 and R 3 together with the carbon atoms to which they are attached form a benzene nng which optionally is substituted by a C 1 6 alkyl, C, 6 alkoxy or hydroxy group; and X is a sulphur or oxygen atom or is a group NR 4 wherein is a hydrogen atom or a C 1-6 alkyl group, which compounds have β-lactamase inhibitory and antibacterial properties A process for their preparation is described, as is their use in pharmaceutical compositions. |
| priorityDate | 1979-08-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 163.